14ʻO nāʻano kiʻekiʻe o ka papillikevirus kanaka kiʻekiʻe (16/18/52

Kākau pōkole:

Ua hoʻohanaʻia ka pahu i nā meaʻike ma Vitro Quiva i 7 ofʻO keʻano o nā PAPellomavirs 3, 20, 58, 69, 69, 69, 69, 69, 69, 69, 69, 69, 69, 69, 69, 69, 69, 69, 69, 69, 69 Ma nā kumuwaiwai kanaka nona nā kānaka i nā mea kanu servical, a me nā wahine viginal swerinal, a me nā wahine viginal swam mau hiʻohiʻona, a me ka hpv 16/58/52 e kōkua ai ka maʻi maʻi a me ka mālamaʻana i ka maʻi HPV.


Huahana kikoʻipiop

Nā Kūlana Huakaʻi

Hua waihona

Hwts-CC019-14 Nāʻano o keʻano o ka papillomacus kanaka kiʻekiʻe (16/18/52 kākau inoa)

Epideminey

ʻO Cervical Cancer kekahi o nā mea nui o nā mea haumia maʻamau maʻamau i ka wahine hānai wahine. Ua hōʻikeʻiaʻo ia e hoʻomau i ka maʻi HPV a me nā maʻi he nui kekahi o nā kumu o ka maʻi cervical o ka cervical. I kēia manawa he nele o nā hana maʻamau iʻaeʻia no ka mālamaʻana i ka maʻi cervical no ka hpv. No laila,ʻike mua a me ka paleʻana o ka maʻi cervical i kumuʻia e ka hpv nā kī i ka paleʻana i ka cervical cervity. Ka hoʻokumuʻana o nā hoʻokolohua maʻalahi a me nā mea hoʻonaninani kūikawā a me nā mea hoʻonaninani hou no nā Pathogensʻo ia ka mea nui no ka maʻi maʻi Cervical.

Kauwe

Nā poʻoaʻenehana

Huanui

≤-18 ℃

'Āmaʻomaʻo 12 mau mahina
ʻAno kiko'ī ʻO Urine Texple, Wahine Servical Swam Swam
Tt ≤28
CV ≤10.0%
Lolulu 300 kope / μl
Kiko'ī ʻAʻohe Cross-reintivity me Ureaplasma Urealyticum, Chllamydia trachosae, mold, Gisseria goghines
Nā mea pili Ma-6000 maoli-manawa nui ka nui o ke cycler (suzhou molandiray co., ltd.),

Biorad CFX96 Nā Kūlana Kūlana Lacr

Biorad CFX OPus 96 Reass PCR System

Nā kahe o ka hana


  • MAUI:
  • ANE:

  • Kākau i kāu leka uila maʻaneʻi a hoʻouna iā mākou